Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts.

Gary R, Aigner M, Moi S, Schaffer S, Gottmann A, Maas S, Zimmermann R, Zingsem J, Strobel J, Mackensen A, Mautner J, Moosmann A, Gerbitz A.

J Transl Med. 2018 May 9;16(1):124. doi: 10.1186/s12967-018-1498-3.

2.

Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B.

Martin LK, Hollaus A, Stahuber A, Hübener C, Fraccaroli A, Tischer J, Schub A, Moosmann A.

PLoS Pathog. 2018 Apr 26;14(4):e1006991. doi: 10.1371/journal.ppat.1006991. eCollection 2018 Apr.

3.

Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells.

Schlott F, Steubl D, Ameres S, Moosmann A, Dreher S, Heemann U, Hösel V, Busch DH, Neuenhahn M.

PLoS One. 2018 Feb 28;13(2):e0193554. doi: 10.1371/journal.pone.0193554. eCollection 2018.

4.

Epstein-Barr virus strain heterogeneity impairs human T-cell immunity.

Cirac A, Stützle S, Dieckmeyer M, Adhikary D, Moosmann A, Körber N, Bauer T, Witter K, Delecluse HJ, Behrends U, Mautner J.

Cancer Immunol Immunother. 2018 Apr;67(4):663-674. doi: 10.1007/s00262-018-2118-z. Epub 2018 Jan 27.

PMID:
29374782
5.

A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.

Link EK, Brandmüller C, Suezer Y, Ameres S, Volz A, Moosmann A, Sutter G, Lehmann MH.

Vaccine. 2017 Sep 12;35(38):5131-5139. doi: 10.1016/j.vaccine.2017.08.019. Epub 2017 Aug 14.

PMID:
28818566
6.

Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.

Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6467-E6475. Epub 2016 Oct 3.

7.

Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.

Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, Zielinski C, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Hammerschmidt W.

J Exp Med. 2016 Sep 19;213(10):2065-80. doi: 10.1084/jem.20160248. Epub 2016 Sep 12.

8.

Quantitative bioimaging of platinum group elements in tumor spheroids.

Niehoff AC, Grünebaum J, Moosmann A, Mulac D, Söbbing J, Niehaus R, Buchholz R, Kröger S, Wiehe A, Wagner S, Sperling M, von Briesen H, Langer K, Karst U.

Anal Chim Acta. 2016 Sep 28;938:106-13. doi: 10.1016/j.aca.2016.07.021. Epub 2016 Jul 25.

PMID:
27619092
9.

Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.

Hubmann M, Fritsch S, Zoellner AK, Prevalsek D, Engel N, Bücklein V, Mumm F, Schulz C, Stemmler HJ, Jäger G, Ledderose G, Kolb HJ, Hausmann A, Hiddemann W, Moosmann A, Tischer J.

J Clin Virol. 2016 Sep;82:33-40. doi: 10.1016/j.jcv.2016.07.002. Epub 2016 Jul 10.

PMID:
27428881
10.

A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus.

Ameres S, Liang X, Wiesner M, Mautner J, Moosmann A.

Front Immunol. 2015 Nov 25;6:598. doi: 10.3389/fimmu.2015.00598. eCollection 2015.

11.

Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox.

Beyer S, Moosmann A, Kahnt AS, Ulshöfer T, Parnham MJ, Ferreirós N, Wagner S, Wacker MG.

Pharm Res. 2015 Dec;32(12):3986-98. doi: 10.1007/s11095-015-1759-2. Epub 2015 Jul 28.

PMID:
26216175
12.

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.

Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A.

PLoS Pathog. 2015 Jun 11;11(6):e1004906. doi: 10.1371/journal.ppat.1004906. eCollection 2015 Jun.

13.

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings.

Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C, Zoellner AK, Bücklein V, Reibke R, Mumm F, Rieger CT, Hill W, Ledderose G, Stemmler HJ, Köhnke T, Jäger G, Kolb HJ, Schmid C, Moosmann A, Hausmann A.

Ann Hematol. 2015 Oct;94(10):1677-88. doi: 10.1007/s00277-015-2423-y. Epub 2015 Jun 10.

PMID:
26055139
14.

Process development of periplasmatically produced single chain fragment variable against epidermal growth factor receptor in Escherichia coli.

Lindner R, Moosmann A, Dietrich A, Böttinger H, Kontermann R, Siemann-Herzberg M.

J Biotechnol. 2014 Dec 20;192 Pt A:136-45.

PMID:
25450642
15.

Mechanisms of graft-versus-leukemia effects after allogeneic stem cell transplantation: effects on the leukemia stem cell?

Kolb HJ, Schmetzer H, Schmid C, Bigalke I, Buhmann R, Moosmann A, Falk C, Reuther S, Schuster F, Borkhardt A.

Leuk Suppl. 2014 Dec;3(Suppl 1):S16-7. doi: 10.1038/leusup.2014.9. Epub 2014 Dec 17. No abstract available.

16.

Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells.

Gabaev I, Elbasani E, Ameres S, Steinbrück L, Stanton R, Döring M, Lenac Rovis T, Kalinke U, Jonjic S, Moosmann A, Messerle M.

J Virol. 2014 Dec;88(24):14326-39. doi: 10.1128/JVI.01691-14. Epub 2014 Oct 1.

17.

CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity.

Ameres S, Besold K, Plachter B, Moosmann A.

J Immunol. 2014 Jun 15;192(12):5894-905. doi: 10.4049/jimmunol.1302281. Epub 2014 May 7.

18.

Purification of PEGylated proteins, with the example of PEGylated lysozyme and PEGylated scFv.

Moosmann A, Müller E, Böttinger H.

Methods Mol Biol. 2014;1129:527-38. doi: 10.1007/978-1-62703-977-2_37.

PMID:
24648098
19.

A palladium label to monitor nanoparticle-assisted drug delivery of a photosensitizer into tumor spheroids by elemental bioimaging.

Niehoff AC, Moosmann A, Söbbing J, Wiehe A, Mulac D, Wehe CA, Reifschneider O, Blaske F, Wagner S, Sperling M, von Briesen H, Langer K, Karst U.

Metallomics. 2014 Jan;6(1):77-81. doi: 10.1039/c3mt00223c.

PMID:
24311052
20.

Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.

Ameres S, Mautner J, Schlott F, Neuenhahn M, Busch DH, Plachter B, Moosmann A.

PLoS Pathog. 2013;9(5):e1003383. doi: 10.1371/journal.ppat.1003383. Epub 2013 May 23.

Supplemental Content

Loading ...
Support Center